News
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
March 12, 2019
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
![1]()
News
Subclinical hypothyroidism boosts immediate risk of heart failure
January 24, 2019
CHICAGO – Large Danish study links subclinical and overt hypothyroidism to immediate risk of heart failure.
![1]()
News
SGLT-2 inhibitors promising for heart failure prevention, not treatment
January 12, 2019
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.
![1]()
News
New diabetes drugs solidify their cardiovascular and renal benefits
January 7, 2019
CHICAGO – Empagliflozin’s heart failure and renal benefits surprised when reported in 2015. The evidence has grown stronger and broader since.
![1]()
News
Nasal glucagon ‘viable alternative’ to intramuscular administration
November 20, 2018
BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon.
![1]()
Opinion
Transforming glycemic control at Norwalk Hospital
November 20, 2018
Norwalk Hospital created a Glycemic Care Team to focus on improving the quality of care for inpatients with diabetes.
![1]()
News
Perioperative diabetes and HbA1c in mortality
October 4, 2018
Do preoperative hemoglobin A1c (HbA1c) and perioperative glucose predict outcomes in patients undergoing noncardiac and cardiac surgeries?
![1]()
News
Plan now for outpatient diabetes tech in the hospital
September 4, 2018
ORLANDO – Getting ahead of the diabetes tech curve.
![1]()
News
Hospitalists target inpatient glycemic control
August 13, 2018
Hyperglycemia in hospitalized patients is an extraordinarily common and growing problem.
![1]()
News
Intranasal naloxone promising for type 1 hypoglycemia
July 17, 2018
ORLANDO – This development could help prevent autonomic failure in T1DM patients.
